Clinical Trials Browser

Phase NA × Unknown × tislelizumab × Clear all

NCT06154967 2023-12-04

To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)

Phase NA Unknown

Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Phase NA Unknown

Adenocarcinoma of Lung

NCT05811793 2023-04-13

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Phase NA Unknown

Glioblastoma

NCT05339581 2022-04-27

iPLENTY-pvtt

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05277675 2022-03-14

RANT

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence